Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002698086 | SCV003723100 | uncertain significance | Inborn genetic diseases | 2022-08-30 | criteria provided, single submitter | clinical testing | The c.674A>G (p.D225G) alteration is located in exon 6 (coding exon 5) of the ANXA11 gene. This alteration results from a A to G substitution at nucleotide position 674, causing the aspartic acid (D) at amino acid position 225 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |